Transglutaminase in epidermis and neurological disease or what makes a good cross-linking substrate.
Unité Propre de Recherche 2228 du Centre National de la Recherche Scientifique, Régulation de la Transcription et Maladies Génétiques, Université Paris Descartes, Paris, France.
Guylaine
G
Hoffner
Amandine
A
Vanhoutteghem
William
W
André
Philippe
P
Djian
D000544:Alzheimer Disease / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D000818:Animals; D003432:Cross-Linking Reagents / Q000378:metabolism*; D000078404:Epidermal Cells; D004817:Epidermis / Q000378:metabolism* / Q000502:physiology; D006801:Humans; D015603:Keratinocytes / Q000378:metabolism / Q000502:physiology; D009422:Nervous System Diseases / Q000209:etiology* / Q000235:genetics / Q000378:metabolism; D010300:Parkinson Disease / Q000209:etiology / Q000235:genetics / Q000378:metabolism; D010455:Peptides / Q000378:metabolism; D013379:Substrate Specificity; D011503:Transglutaminases / Q000235:genetics / Q000378:metabolism* / Q000502:physiology*
D003432:Cross-Linking Reagents; D010455:Peptides; C097188:polyglutamine; D011503:Transglutaminases